
HistoricalNonfiction
Track this book
You choose which shelves are public. Progress and read dates stay yours.
About
It began with a promising cancer drug, the brainchild of a gifted researcher, and grew into an insider trading scandal that ensnared one of America's most successful women. The story of ImClone Systems and its "miracle" cancer drug, Erbitux, is the quintessential business saga of the late 1990s. It's the story of big money and cutting-edgescience, celebrity, greed, and slipshod business practices; the story of biotech hype and hope and every kind of excess.At the center of it all stands a single, enigmatic figure named Sam Waksal. A brilliant, mercurial, and desperate-to-be-liked…
More by Alex Prud'homme
All booksMore like this








Reviews
Rating integrity
HealthyCounted ratings come from accounts older than 7 days and were made on or after publication. Finished readers weigh ×1.0. Readers who have not finished yet weigh ×0.5. Did-not-finish ratings are shown but not counted.
Editions
8 editions- Paperback · English · 2010Collins · 432 pages · 9780060555573
- Ebook · English · 2007HarperCollins · 9780061371837
- Other · English · 2009Cell GameHarperCollins Publishers · 9780061865626
- Other · English · 2007Cell GameHarperCollins Publishers · 9780061371882
- Other · English · 2007Cell GameHarperCollins Publishers · 9780061371868
- Other · English · 2007Cell GameHarperCollins Publishers · 9780061371875
Antineoplastic agents industryBiographyBusinessBusinessmenCancerChemotherapyCorrupt practicesDrugs
